NCT06014047Not yet recruiting
Radial Artery Versus No-touch Saphenous Vein
Graft Patency Between the Radial Artery and the No-touch Saphenous Vein in Coronary Artery Bypass Grafting Study (GRAFT-CAB Study)
Source: ClinicalTrials.gov · Last updated 17 Oct 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study evaluates the short-term and long-term patency of the radial artery and the No-touch vein in patients undergoing isolated on-pump/off-pump coronary artery bypass graft (CABG) surgery. A total of at least 774 patients undergoing isolated on-pump/off-pump CABG will be consecutively recruited from Fuwai Hospital and randomly assigned to receive radial artery or No-touch saphenous vein as their second graft. All participants will be invited for clinical follow-up and 64-slice multislice computed tomography angiography (MSCTA) analysis at 3 months and 12 months post-operatively.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 774 (estimated)
- First submitted
- 23 Aug 2023
- Start date
- Nov 2023
- Primary completion date
- Oct 2026
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Diseases
- Coronary artery disease
- NCT number
- NCT06014047
What you commit to
- Study type: Interventional
- Planned participants: 774
- From Nov 2023 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Urgent or Redo CABG surgery
- Concomitant cardiac or vascular procedures (i.e. valve repair or replacement, Morrow procedure)
- Planed endarterectomy of coronary artery before surgery
Other illness
- A positive Allen test, radial artery plaque on ultrasound or a history of vasculitis or Raynaud's syndrome
- Known allergy to radiographic contrast media
- Malignant tumor or other severe systemic diseases
- Contraindications for dual antiplatelet therapy, such as active gastroduodenal ulcer
Other
- Varicose great saphenous vein or venous tortuosity and judged as can not be used in operation by surgeons
- Combined with other irreversible organ failures
- Participant of other ongoing clinical trials in 30 days.
Who the study is looking for
- Age more than 18 years old
- First time undergo isolated CABG surgery
- Severe three-vessel disease (Left anterior decending artery, Left circumflex artery, Right coronoary artery lesion with more than 75% stenosis)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fuwai Hospital Chinese Academay of Medical Science and National Center for Cardiovascular Diseases Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.